Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Calypte executives set up new company:

This article was originally published in Clinica

Executive Summary

Calypte Biomedical's founder and chief scientific officer, Dr Howard Urnovitz, and its chairman, William Boeger, have set up a new company to examine new methods to detect aberrant genes in patients with chronic diseases. The new company, Chronix Biomedical, will be financed independently. Alameda, California-based Calypte, which makes HIV-related tests, will retain the rights to any urine-based diagnostic tests resulting from the research at Chronix. Dr Urnovitz and Mr Boeger will retain their current positions at Calypte.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT075636

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel